SLNO Operating Expenses

Soleno Therapeutics Inc · Operating Expenses

SLNO logo

SLNO Operating Expenses

Latest reported$193.34M
SLNO TTM Operating Expenses ($3.85M → $193.34M)
High-resolution chart · PNG

SLNO operating expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Soleno Therapeutics Inc Operating Expenses — Trailing twelve months (TTM) (USD)
Period endingOperating Expenses (USD)
193,337,000
177,437,000
186,117,000
223,557,000
207,808,000
185,540,000
140,334,000
70,504,000
56,390,000
41,384,000
33,084,000
28,937,000
27,093,000
24,397,000
21,788,000
23,839,000
28,145,000
13,216,000
18,172,000
17,743,000
17,851,000
17,725,000
16,648,000
14,896,000
9,143,000
23,197,000
19,874,000
17,419,000
15,459,000
13,734,000
12,884,123
11,923,123
11,612,123
10,831,123
11,141,597
11,323,597
11,567,597
13,550,597
14,024,618
14,372,618
14,013,618
12,194,618
10,548,729
8,652,729
6,905,729
5,160,217
3,874,271
3,544,271
3,413,318
3,847,607
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.